Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.12M Buy
10,173
+1,790
+21% +$1.19M 0.08% 165
2026
Q1
$4.57M Buy
8,383
+669
+9% +$273K 0.05% 234
2025
Q4
$2.42M Buy
7,714
+892
+13% +$283K 0.03% 401
2025
Q3
$2.22M Sell
6,822
-1,020
-13% -$234K 0.03% 375
2025
Q2
$1.84M Buy
7,842
+726
+10% +$131K 0.03% 397
2025
Q1
$933K Buy
7,116
+1,074
+18% +$150K 0.02% 496
2024
Q4
$828K Buy
6,042
+3,821
+172% +$525K 0.01% 520
2024
Q3
$225K Buy
+2,221
New +$176K ﹤0.01% 807

Other funds holding AGX

NewEdge Wealth's AGX Position: Q2 2026 in Review

NewEdge Wealth increased its Argan (AGX) stake by 21% in Q2 2026, buying an estimated $1.19M and bringing the position to 10,173 shares worth $8.12M. The position accounts for 0.08% of the portfolio, ranked #165.

NewEdge Wealth first reported a position in AGX in Q3 2024 and has held it in 8 quarters since. 564 funds tracked by Wall St. Rank hold AGX as of Q2 2026.

  • NewEdge Wealth held 10,173 shares of Argan worth $8.12M as of Q2 2026.
  • NewEdge Wealth bought 1,790 Argan shares in Q2 2026, an estimated $1.19M.
  • Argan made up 0.08% of NewEdge Wealth's portfolio in Q2 2026, its #165 holding.
  • NewEdge Wealth first reported a position in Argan in Q3 2024 and has held it in 8 quarters since.
  • 564 funds tracked by Wall St. Rank held Argan as of Q2 2026.

Based on NewEdge Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.